<DOC>
	<DOC>NCT00541775</DOC>
	<brief_summary>The purpose of this study is to test the safety and effectiveness of sitagliptin in patients with type 2 diabetes.</brief_summary>
	<brief_title>Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient has Type 2 diabetes Currently taking metformin &gt;1500 mg/day for at least 10 weeks Male or female Patient has peripheral edema History of type 1 diabetes Patient required insulin within prior 8 weeks Have participated or are currently participating in another study with an investigational compound or device within 12 weeks of starting this study Participating in a weight loss program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>